What is the name of your organization?
WomGuard Foundation
What is the name of your solution?
CerviBridge
Provide a one-line summary or tagline for your solution.
A portable AI embedded device improving early cervical cancer detection and access in remote areas.
In what city, town, or region is your solution team headquartered?
Mengo, Kampala
In what country is your solution team headquartered?
UGA
What type of organization is your solution team?
Nonprofit
Film your elevator pitch.
What specific problem are you solving?
Cervical cancer is the leading cause of cancer-related deaths among women in Uganda and other low-resource settings, despite being preventable and treatable when detected early. In Uganda alone, over 6,900 women are diagnosed with cervical cancer annually, and more than 4,600 die from the disease, largely due to late-stage diagnosis and lack of access to timely screening services (HPV Information Centre, 2023). Globally, cervical cancer affects over 600,000 women every year and causes more than 340,000 deaths, with over 90% of these deaths occurring in low- and middle-income countries (WHO, 2022). In rural Ugandan communities, healthcare facilities are often under-resourced, and screening programs are inaccessible to many due to distance, cost, lack of awareness, and shortage of trained personnel.
Factors contributing to this include limited diagnostic tools, centralized screening in urban hospitals, stigma, and lack of education about reproductive health. As a result, women in remote areas are disproportionately affected, with many only seeking care when symptoms become severe and survival chances are low.
WomGuard Foundation addresses these barriers by offering a portable, AI-powered cervical cancer screening solution that enables frontline health workers to deliver accurate, low-cost, and timely diagnostics even in rural, underserved communities—bringing early detection directly to the women who need it most.
What is your solution?
CaviScope is a portable, AI-powered cervical cancer screening device designed to bring early detection directly to underserved communities. It empowers frontline health workers to screen women in remote areas without relying on specialist doctors or fully equipped hospitals.
The device uses a high-resolution camera and a speculum-free imaging system to comfortably capture cervical images. These images are instantly analyzed by a built-in AI model trained on thousands of annotated clinical cases to detect early signs of cervical abnormalities, such as pre-cancerous lesions or inflammation.
Results are generated in real time, providing immediate feedback to guide the next steps whether it's reassurance, monitoring, or urgent referral. CaviScope works offline, stores data securely, and syncs with mobile devices when connectivity is available, enabling record-keeping and follow-up care.
Built for low-resource settings, our device eliminates the long travel distances, delays, and diagnostic gaps that often prevent women from accessing life-saving screenings. By combining comfort, portability, and intelligent diagnostics, CaviScope makes cervical cancer screening faster, more accessible, and more equitable transforming how communities tackle one of the most preventable yet deadly diseases affecting women
Who does your solution serve, and in what ways will the solution impact their lives?
CaviScope is designed to serve women of reproductive age in underserved and remote communities, particularly in Uganda and across Sub-Saharan Africa, where cervical cancer is a leading cause of cancer-related deaths among women. These women are often underserved due to systemic barriers such as limited access to screening facilities, long distances to urban hospitals, high costs, stigma, and the discomfort of traditional speculum-based screening. As a result, many cases are diagnosed at an advanced stage, when treatment is less effective or unavailable.
WomGuard Foundation also directly empowers community health workers "the frontline caregivers" who are often the only point of contact for health services in rural areas especially in Uganda. With minimal training, CHWs can use the portable, AI-powered CaviScope device to conduct safe, speculum-free screenings and generate instant results. This improves early detection, enables timely referrals, and significantly reduces the diagnostic delay. By decentralizing cervical cancer screening, CaviScope not only makes life-saving care more accessible and dignified for women but also builds long-term capacity within local health systems. In its first rollout, CaviScope aims to reach over 100,000 women, with the potential to scale and positively impact millions of lives globally through equitable, community-led healthcare delivery